Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | ATM | Q13315 | 1/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | MTOR | P42345 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | VCP | P55072 | 1/20 | 0.57 |
| ▸ | PGR | P06401 | 1/20 | 0.57 |
| ▸ | AR | P10275 | 1/20 | 0.57 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
| ▸ | KDR | P35968 | 1/20 | 0.57 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isosafrole SCHEMBL7075676 | 1.00 | CYP3A4 (1.00) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL266169 | 1.00 | CYP3A4 (1.00) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL30302237 | 1.00 | CYP3A4 (1.00) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL29365996 | 1.00 | CYP3A4 (1.00) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL14764127 | 1.00 | CYP3A4 (1.00) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL345862 | 1.00 | CYP3A4 (1.00) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL28514792 | 0.98 | CYP3A4 (0.96) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL28514793 | 0.98 | CYP3A4 (0.96) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL10931493 | 0.91 | CYP3A4 (0.83) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 | |
| Isosafrole SCHEMBL30302238 | 0.90 | CYP3A4 (0.81) | CYP3A4ATMCYP19A1ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210052547-A1 | USE OF STIRIPENTOL AND THEIR DERIVATIVES FOR DECREASING URINARY OXALATE CONCENTRATION IN AN INDIVIDUAL | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (NSERM) (FR) | 2021-02-25 | — | — | US | claimed |
| EP-3416955-B1 | USE OF STIRIPENTOL AND THEIR DERIVATIVES FOR DECREASING URINARY OXALATE CONCENTRATION IN AN INDIVIDUAL | INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECH MÉDICALE (INSERM) (FR) | 2020-09-09 | — | — | EP | claimed |
| EP-1140894-B1 | PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS | ENDURA SPA (IT) | 2003-12-17 | — | — | EP | claimed |
| US-6342613-B1 | REACTING PYROCATECHOL WITH DIHALO- OR DI-ALKOXYALKANE, ACYLATING BENZO(1,3)DIOXOLE DERIVATIVE FORMED IN PRESENCE OF CATALYST, REDUCING TO 5-(ALPHA-HYDROXYALKYL)BENZO(1,3)DIOXOLE | ENDURA S.P.A. (IT) | 2002-01-29 | — | — | US | claimed |
| EP-1140894-A1 | PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS | ENDURA S.p.A. (IT) | 2001-10-10 | — | — | EP | claimed |
| WO-2000040575-A1 | PROCESS FOR THE SYNTHESIS OF 5-(α -HYDROXYALKYL) BENZO[1, 3]DIOXOLS | ENDURA S.P.A. (IT) | 2000-07-13 | — | — | WO | claimed |
| JP-10120674-A | — | — | None | — | — | JP | disclosed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| CN-114098141-B | Electronic atomized liquid containing borneol plant components and preparation method thereof | 深圳市真味生物科技有限公司 | 2023-02-10 | — | — | CN | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| CN-115518096-A | Integrated comprehensive extraction and separation method for effective components of epimedium | 李玉山 | 2022-12-27 | — | — | CN | disclosed |
| CN-114098141-A | Electronic atomized liquid containing borneol plant components and preparation method thereof | 深圳市真味生物科技有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-114007734-A | Method for preparing capsules | 宝洁公司 | 2022-02-01 | — | — | CN | disclosed |
| US-6252092-B1 | CATALYTIC HYDROGENATION OF 4-ACYLPHENOL; ACETYLATION; REACTING WITH A LEWIS ACID; THEN HYDROGEN PEROXIDE; CYCLIZATION | ENDURA S.P.A. (IT) | 2001-06-26 | — | — | US | disclosed |
| EP-1048664-A2 | Process for the synthesis of 5-allybenzodioxoles | ENDURA S.p.A. (IT) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000040575-A1 | PROCESS FOR THE SYNTHESIS OF 5-(α -HYDROXYALKYL) BENZO[1, 3]DIOXOLS | ENDURA S.P.A. (IT) | 2000-07-13 | — | — | WO | disclosed |
| US-6020287-A | USING MIXTURE OF HERBICIDE AND PHENYL-SUBSTITUTED OLEFIN COMPOUND | MONSANTO COMPANY (US) | 2000-02-01 | — | — | US | disclosed |
| JP-H10120674-A | PRODUCTION OF 2-METHYL-3-(3,4-METHYLENEDIOXYPHENYL) ACRYLIC ALDEHYDE | T HASEGAWA CO LTD | 1998-05-12 | — | — | JP | disclosed |
| EP-0780340-A1 | Intercalates and exfoliates formed with functional monomeric organic compounds; composite materials containing same and methods of modifying rheology therewith | AMCOL INTERNATIONAL CORPORATION (US) | 1997-06-25 | — | — | EP | disclosed |
| US-4138411-A | RUTHENIUM OR OSMIUM CATALYST | RHONE-POULENC S. A. (FR) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210052547-A1 | USE OF STIRIPENTOL AND THEIR DERIVATIVES FOR DECREASING URINARY OXALATE CONCENTRATION IN AN INDIVIDUAL | OAT, OXER1, SLCO2A1 | CYP3A4 1737/4885ATM 4295/4885CYP19A1 447/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | CYP3A4 2348/4885ATM 241/4885CYP19A1 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.